201 related articles for article (PubMed ID: 14998298)
21. [A case report of a giant cell carcinoma of the thyroid].
Murakami N; Kawaura Y; Sasaki M; Munemoto Y; Iwa T; Nonomura A
Gan No Rinsho; 1989 Jul; 35(8):927-32. PubMed ID: 2746867
[TBL] [Abstract][Full Text] [Related]
22. Analysis by comparative genomic hybridization of epithelial and spindle cell components in sarcomatoid carcinoma and carcinosarcoma: histogenetic aspects.
Torenbeek R; Hermsen MA; Meijer GA; Baak JP; Meijer CJ
J Pathol; 1999 Nov; 189(3):338-43. PubMed ID: 10547594
[TBL] [Abstract][Full Text] [Related]
23. Sarcomatoid basal cell carcinoma--predilection for osteosarcomatous differentiation: a series of 11 cases.
Mc Menamin ME; Goh SG; Poblet E; Gostelow BE; Robson A; Calonje E
Am J Surg Pathol; 2006 Oct; 30(10):1299-308. PubMed ID: 17001162
[TBL] [Abstract][Full Text] [Related]
24. Hürthle cell carcinoma of the thyroid with contralateral malignant pleural effusion.
Hsu KF; Hsieh CB; Duh QY; Chien CF; Li HS; Shih ML
Onkologie; 2009 Feb; 32(1-2):47-9. PubMed ID: 19209020
[TBL] [Abstract][Full Text] [Related]
25. [Thyroidal oxyphilic tumors].
Sabo R; Zohar Y; Schwartz A; Segal K
Harefuah; 1994 Feb; 126(4):183-6, 240. PubMed ID: 8168757
[TBL] [Abstract][Full Text] [Related]
26. Hürthle cell tumors of the thyroid gland. Personal experience and review of literature.
Bononi M; De Cesare A; Cangemi V; Fiori E; Galati G; Giovagnoli MR; Izzo L; Cimitan A; Meucci M; Cavallaro A
Anticancer Res; 2002; 22(6B):3579-82. PubMed ID: 12552959
[TBL] [Abstract][Full Text] [Related]
27. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
29. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
Kim YW; Do IG; Park YK
Pathol Res Pract; 2006; 202(11):759-65. PubMed ID: 17029809
[TBL] [Abstract][Full Text] [Related]
30. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
[TBL] [Abstract][Full Text] [Related]
32. Fine needle aspiration cytology of unsuspected metastatic hurthle cell carcinoma of the thyroid and its pitfalls: a report of two cases.
Lallu S; Naran S; Bethwaite P
Diagn Cytopathol; 2007 Jul; 35(7):439-43. PubMed ID: 17580356
[TBL] [Abstract][Full Text] [Related]
33. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
Amatya VJ; Takeshima Y; Kaneko M; Inai K
Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
[TBL] [Abstract][Full Text] [Related]
34. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
35. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
36. Endometrial carcinoma recurring as carcinosarcoma: report of two cases.
Ferrandina G; Zannoni GF; Martinelli E; Vellone V; Prisco MG; Scambia G
Pathol Res Pract; 2007; 203(9):677-81. PubMed ID: 17646054
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 expression in primary thyroid carcinomas.
Sporny S; Slowinska-Klencka D; Ratynska M
Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
[TBL] [Abstract][Full Text] [Related]
38. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases.
Carter MR; Hornick JL; Lester S; Fletcher CD
Am J Surg Pathol; 2006 Mar; 30(3):300-9. PubMed ID: 16538049
[TBL] [Abstract][Full Text] [Related]
39. Review article: pulmonary sarcomatoid carcinomas: a practical overview.
Pelosi G; Sonzogni A; De Pas T; Galetta D; Veronesi G; Spaggiari L; Manzotti M; Fumagalli C; Bresaola E; Nappi O; Viale G; Rosai J
Int J Surg Pathol; 2010 Apr; 18(2):103-20. PubMed ID: 19124452
[TBL] [Abstract][Full Text] [Related]
40. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
